24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

24/7 MN (AMEX: AIM) AIM IMMUNOTECH INC. shares have perked up more than 16% in pre-market trading on light volume and less than 1,000 trades as the company announces additional patients for its studies.

AIM ImmunoTech reports additional patient data from Single-Center Named Patient Program evaluating Ampligen as maintenance therapy for advanced pancreatic cancer indicating additional progression-free and overall survival over previously published data

RelatedNews

24/7 Market News Lunch Break 25 Sept 2023

24/7 Market News Snapshot 25 Sept 2023

ESS Tech Collaborates with Honeywell to Accelerate Iron Flow Battery Energy Storage Systems Deployment

TransCode Therapeutics’ Lead Therapeutic Candidate, TTX-MC138, effectively engaged its Target

Vapotherm HVNI technology outperforms standard oxygen therapy for treatment of acute asthma in children according to Pilot Study

Want more news like this? Check out our homepage!

Recent News

24/7 Market News Lunch Break 25 Sept 2023

24/7 Market News Snapshot 25 Sept 2023

ESS Tech Collaborates with Honeywell to Accelerate Iron Flow Battery Energy Storage Systems Deployment

TransCode Therapeutics’ Lead Therapeutic Candidate, TTX-MC138, effectively engaged its Target

Vapotherm HVNI technology outperforms standard oxygen therapy for treatment of acute asthma in children according to Pilot Study

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Search by keyword

Add New Playlist